Latka logo
Latus Bio logo

Latus Biorevenue

Philadelphia, PennsylvaniaFounded 2022CEO Wayne Tupuola

Latus is a biotechnology company that develops innovative gene therapy candidates using precision delivery with the goal of improving the lives of patients, focusing on disorders of the central nervous system and peripheral diseases.

latusbio.comLinkedInUpdated Sep 10, 2026
Annual revenue
$6.2M
Sep 2025EST
Employees
31
Sep 2025

Latus Bio revenue

Latus Bio has not published its revenue. Growjo puts it at about $6.2M a year (September 2025).

$0
$2M
$4M
$6M
$0
–
$6.2M
20222023–242025
ReportedEstimateFounded 2022 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$6.2MESTGrowjo estimate

Latus Bio CEO & employees

Wayne Tupuola is CEO of Latus Bio. Latus Bio has 31 employees (September 2025, LinkedIn).

0
10
20
30
31
2025
ReportedOne figure per year; a reported figure wins over an estimate

Latus Bio FAQ

What is Latus Bio's revenue?

Growjo estimates Latus Bio's revenue at about $6.2M a year (September 2025). The company hasn't published its own figure.

How many employees does Latus Bio have?

Latus Bio has 31 employees as of September 2025, according to LinkedIn.

Who is the CEO of Latus Bio?

Wayne Tupuola is the CEO of Latus Bio.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Latus Bio? Join the podcast